Lupus nephritis: the evolving role of novel therapeutics.

Abstract excerpt

Immune complex accumulation in the kidney is the hallmark of lupus nephritis and triggers a series of events that result in kidney inflammation and injury. Cytotoxic agents and corticosteroids are standard of care for lupus nephritis treatment, but are associated with considerable morbidity and suboptimal outcomes. Recently, there has been interest in using novel biologic agents and small molecules to treat lupus...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Abatacept
• Share to Acute Kidney Injury
• Share to Antibodies, Monoclonal, Murine-Derived